Protocol - Pain Intensity - Adolescent and Adult
This protocol consists of a single self-administered question from the Patient-Reported Outcomes Measurement Information System (PROMIS®) Numeric Rating Scale v.1.0 assessing acute and chronic pain intensity during the past 7 days. The item is measured on an 11-point scale. This protocol was validated in individuals aged 18 years and older.
This question about pain intensity from Patient-Reported Outcomes Measurement Information System (PROMIS®) are also included in the Quality of Life - Adult measure. Therefore, selecting these two protocols together will result in selecting the same questions multiple times.
The Sickle Cell Disease Pain Working Group notes that numeric rating scales (NRS) can be used for children as young as 8 years. For studies that include older children and a mix of children and adults, the NRS might be preferable to provide continuity.
The PhenX Working Group recommends this PROMIS® protocol. For additional information regarding PROMIS® instruments (including scoring, validity, and interpretation) please visit: www.healthmeasures.net. For specific information about this instrument, please visit: www.healthmeasures.net/index.php?option=com_instruments&view=measure&id=896&Itemid=992
PROMIS® Numeric Rating Scale v.1.0 - Pain Intensity - 1a
Please respond to the question by marking one box.
In the past 7 days…
How would you rate your pain on average?
|[ ]0||[ ]1||[ ]2||[ ]3||[ ]4||[ ]5||[ ]6||[ ]7||[ ]8||[ ]9||[ ]10|
©2008-2017 PROMIS Health Organization
Personnel and Training Required
|Specialized requirements for biospecimen collection||No|
|Average time of greater than 15 minutes in an unaffected individual||No|
Mode of Administration
Adults aged 18 years and older
The Patient-Reported Outcomes Measurement Information System (PROMIS®) pain intensity scales have been tested and have been found to be reliable and comparable to established measures of the same content areas. They have standardized scoring and are quick and easy to administer via either paper and pencil or as a computer-based instrument. Additionally, they may be adapted to chronic patient populations.
English, Other languages available at source
|caDSR Common Data Elements (CDE)||Pain Intensity Scale-Adolescent and Adult Assessment Score||7997192||CDE Browser|
Process and Review
Protocol Name from Source
Patient-Reported Outcomes Measurement Information System (PROMIS®) Numeric Rating Scale v.1.0 - Pain Intensity - 1a
U.S. Department of Health and Human Services, National Institutes of Health (HHS-NIH). Patient-Reported Outcomes Measurement Information System (PROMIS), 2008-2017, Numeric Rating Scale v.1.0 - Pain Intensity - 1a.
Becker, H., Stuifbergen, A., & Zhang, W. (2019). Functional and health promotion predictors of PROMIS® scores in people with multiple sclerosis. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 38(5), 431-434.
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., DeVellis, R., DeWalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Pilkonis, P., Revicki, D., Rose, M., Weinfurt, K., Hays, R., Lai, J-S., & on behalf of the PROMIS Cooperative Group. (2010). The Patient Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. Journal of Clinical Epidemiology, 63(11), 1179-1194.
Jacob, E., Miaskowski, C., Savedra, M., Beyer, J., Treadwell, M., & Styles, L. (2003). Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain, 102, 187-193.
Janssen, S. J., Pereira, N., Thio, Q., Raskin, K. A., Bramer, J., Lozano-Calderon, S. A., & Schwab, J. H. (2019). Physical function and pain intensity in patients with metastatic bone disease. Journal of Surgical Oncology, 120(3), 376-381.
Master, S., Arnold, C., Davis, T., Shi, R., & Mansour, R. P. (2016). Anxiety, depression, pain intensity and interference in adult patients with sickle cell disease. Blood, 128(22), 1312.
|Variable Name||Variable ID||Variable Description||dbGaP Mapping|
|PX860401010000||In the past 7 days, how would you rate your more||N/A|
May 18, 2022
This measure assesses the magnitude of pain experienced by an individual.
Pain intensity can impact social interactions, physical and mental health, and overall quality of life. Pain is a commonly occurring symptom that affects individuals with a variety of diseases and conditions, including sickle cell disease.
pain intensity - adolescent and adult, PROMIS® Patient-Reported Outcomes Measurement Information System, PROMIS, National Institutes of Health, NIH, pain, Pain measurement, Pain assessment, sickle cell disease, SCD, type 1 diabetes, asthma, atopic dermatitis
|Protocol ID||Protocol Name|
|860401||Pain Intensity - Adolescent and Adult|
|860402||Pain Intensity - Child|
|860403||Pain Intensity - Toddler|
There are no publications listed for this protocol.